The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -85.45% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -81.38%. Over the past 30 days, the price of FBIO has leaped by -37.00%. And in the last five days, it has fallen by -31.25%.
The current stock price for Fortress Biotech Inc (FBIO) is $1.43. The stock experienced a significant increase during the last trading session, reaching $1.44 after opening at $1.44. It dipped to a low of $1.30 before ultimately closing at $1.38.
Fortress Biotech Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $17.40 on 01/18/23, with the lowest value being $1.24 on 11/10/23.
52-week price history of FBIO Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Fortress Biotech Inc’s current trading price is -91.78% away from its 52-week high, while its distance from the 52-week low is 15.32%. The stock’s price range over this timeframe has been between $1.24 and $17.40. The shares of the Healthcare sector company recorded a trading volume of approximately 0.51 million for the day, which was comparatively higher than the average daily volume of 96910.0 over the last three months.
The Connection Between Financial Performance and Market Capitalization
Fortress Biotech Inc (FBIO) has experienced a quarterly decline of -78.10% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.78M and boasts a workforce of 187 employees.
Expert Opinions: Analysts’ Ratings for Fortress Biotech Inc
As of right now, 5 analysts are rating Fortress Biotech Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.4500, with a change in price of -7.0000. Similarly, Fortress Biotech Inc recorded 87,211 in trading volume during the last 100 days, posting a change of -83.04%.
FBIO’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for FBIO stands at 4.44. Similarly, the long-term debt-to-equity ratio is also 3.88.
FBIO Stock Stochastic Average
Fortress Biotech Inc’s raw stochastic average for the past 50 days is currently at 3.87%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 14.62%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 10.31% and 7.73%, respectively.